Fisher & Paykel Healthcare Corporation Limited (NZSX:FPH, ASX:FPH) announced today that it intends to release on Friday, 29 May 2015 its financial results for the year ended 31 March 2015. The release will be issued shortly after 9:00am NZST, 7:00am AEST (5:00pm USEDT, Thursday, 28 May).
Fisher & Paykel Healthcare will host a conference call on Friday, 29 May 2015 to review the results and to discuss the outlook for the 2016 financial year. The conference call is scheduled to begin at 10:00am NZST, 8:00am AEST (6:00pm USEDT, Thursday, 28 May) and will be broadcast simultaneously over the Internet.
To listen to the webcast, access the company’s website at www.fphcare.co.nz/investor. Please allow extra time prior to the webcast to visit the site and download the streaming media software if required. An online archive of the event will be available approximately two hours after the webcast and will remain on the site for two weeks.
To attend the conference call, participants will need to dial in to one of the numbers below at least 5 minutes prior to the scheduled call time and identify yourself to the operator. When prompted, please quote the conference code of: 34898546.
An audio replay of the conference call will be available approximately 2 hours after the call and will be accessible for two weeks by dialing one of the numbers below. When prompted please enter the conference code of: 34898546.
Fisher & Paykel Healthcare is a leading designer, manufacturer and marketer of products and systems for use in respiratory care, acute care, surgery and the treatment of obstructive sleep apnea. The company’s products are sold in more than 120 countries worldwide. For more information about the company, visit our website www.fphcare.com.
Fisher & Paykel Healthcare to Announce Full Year Results on 29 May 2015
Delivering respiratory support for spontaneously breathing patients
Full face masks designed for comfort and care
Providing Optimal Humidity for intubated patients
Establish effective spontaneous breathing or assist ventilation of the lungs
Respiratory support that replaces spontaneous breathing
Noninvasive respiratory support that provides a continuous distending pressure
Noninvasive respiratory support that delivers high flows of blended air and oxygen
Delivering warm, humidified carbon dioxide in laparoscopic and open surgery
Designed to work in harmony with the way patients naturally breathe while they sleep
F&P SleepStyle - designed to strike the balance between comfort and effective treatment
Nasal High Flow and Humidification for patients at home and in long term care
Home respiratory therapies that deliver humidification via a mask or tracheotomy tube to support and complement the airway’s natural-defense mechanisms
A flow range of 2 to 60 L/min allows for use across the care continuum - from the most acute hospital environment to the home
With Optiflow you can independently titrate flow and FiO2 according to your patient's needs
Introducing F&P Evora™ Full, our new compact full face CPAP* mask. Evora Full is minimal contact with full performance featuring our next generation of Dynamic Support Technology™.
A premium performance respiratory humidifier designed to be easy to set up and use, minimize condensate and provide advanced protection
Updates and support for healthcare professionals
Looking after our people, suppliers, communities and the environment